These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 16827136

  • 21. Cyclooxygenase-2 inhibition increases gastric tone and delays gastric emptying in rats.
    Santos CL, Medeiros BA, Palheta-Junior RC, Macedo GM, Nobre-e-Souza MA, Troncon LE, Santos AA, Souza MH.
    Neurogastroenterol Motil; 2007 Mar; 19(3):225-32. PubMed ID: 17300293
    [Abstract] [Full Text] [Related]

  • 22. Transforming Growth Factor-alpha reduces carcinogen-induced DNA damage in mini-organ cultures from head-and-neck cancer patients.
    Baumeister P, Schwenk-Zieger S, Reiter M, Welz C, Harréus U.
    Mutat Res; 2009 Mar; 677(1-2):42-5. PubMed ID: 19539778
    [Abstract] [Full Text] [Related]

  • 23. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
    Tang BD, Zeng ZR, Hu PJ.
    Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
    [Abstract] [Full Text] [Related]

  • 24. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
    Jacob S, Laury-Kleintop L, Lanza-Jacoby S.
    J Surg Res; 2008 May 01; 146(1):135-42. PubMed ID: 17950326
    [Abstract] [Full Text] [Related]

  • 25. The influence of high doses of vitamin C and zinc on oxidative DNA damage.
    Harréus U, Baumeister P, Zieger S, Matthias C.
    Anticancer Res; 2005 May 01; 25(5):3197-201. PubMed ID: 16101127
    [Abstract] [Full Text] [Related]

  • 26. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
    Kwak YE, Jeon NK, Kim J, Lee EJ.
    Ann N Y Acad Sci; 2007 Jan 01; 1095():99-112. PubMed ID: 17404023
    [Abstract] [Full Text] [Related]

  • 27. Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats.
    Zhang X, Dong F, Mayer GE, Bruch DC, Ren J, Culver B.
    Neuroscience; 2007 Dec 19; 150(4):950-8. PubMed ID: 17988800
    [Abstract] [Full Text] [Related]

  • 28. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain.
    Guo JY, Li CY, Ruan YP, Sun M, Qi XL, Zhao BS, Luo F.
    Eur J Pharmacol; 2009 Jun 10; 612(1-3):54-60. PubMed ID: 19356723
    [Abstract] [Full Text] [Related]

  • 29. Celecoxib inhibits 5-lipoxygenase.
    Maier TJ, Tausch L, Hoernig M, Coste O, Schmidt R, Angioni C, Metzner J, Groesch S, Pergola C, Steinhilber D, Werz O, Geisslinger G.
    Biochem Pharmacol; 2008 Oct 01; 76(7):862-72. PubMed ID: 18692027
    [Abstract] [Full Text] [Related]

  • 30. Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes.
    Walmesley AJ, Zweiri J, Christmas SE, Watson AJ.
    J Immunother; 2007 Sep 01; 30(6):614-23. PubMed ID: 17667525
    [Abstract] [Full Text] [Related]

  • 31. The cytotoxicity of celecoxib towards cardiac myocytes is cyclooxygenase-2 independent.
    Hasinoff BB, Patel D, Wu X.
    Cardiovasc Toxicol; 2007 Sep 01; 7(1):19-27. PubMed ID: 17646679
    [Abstract] [Full Text] [Related]

  • 32. Chemoprevention by celecoxib and mutagen sensitivity of cyclin d1 in patients with oropharyngeal carcinoma.
    Reiter M, Baumeister P, Hartmann M, Schwenk-Zieger S, Harréus U.
    In Vivo; 2014 Sep 01; 28(1):49-53. PubMed ID: 24425835
    [Abstract] [Full Text] [Related]

  • 33. [Effects of selective cyclooxygenase-2 inhibitor on proliferation and apoptosis of human bladder cancer cell line T24].
    Zhang J, Xu ZQ, Hu Q, Qiu XW, Wang ZR.
    Ai Zheng; 2007 Apr 01; 26(4):377-81. PubMed ID: 17430655
    [Abstract] [Full Text] [Related]

  • 34. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.
    Dudhgaonkar SP, Tandan SK, Kumar D, Raviprakash V, Kataria M.
    Inflammopharmacology; 2007 Oct 01; 15(5):188-95. PubMed ID: 17943250
    [Abstract] [Full Text] [Related]

  • 35. DNA-PKcs-dependent modulation of cellular radiosensitivity by a selective cyclooxygenase-2 inhibitor.
    Kodym E, Kodym R, Chen BP, Chen DJ, Morotomi-Yano K, Choy H, Saha D.
    Int J Radiat Oncol Biol Phys; 2007 Sep 01; 69(1):187-93. PubMed ID: 17707272
    [Abstract] [Full Text] [Related]

  • 36. How specific are "target-specific" drugs? Celecoxib as a case in point.
    Sadée W, Bohn L.
    Mol Interv; 2006 Aug 01; 6(4):196-8. PubMed ID: 16960141
    [Abstract] [Full Text] [Related]

  • 37. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
    Kim SH, Kim SH, Song YC, Song YS.
    Ann N Y Acad Sci; 2009 Aug 01; 1171():635-41. PubMed ID: 19723114
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and biological evaluation of methanesulfonamide analogues of rofecoxib: Replacement of methanesulfonyl by methanesulfonamido decreases cyclooxygenase-2 selectivity.
    Zarghi A, Praveen Rao PN, Knaus EE.
    Bioorg Med Chem; 2007 Jan 15; 15(2):1056-61. PubMed ID: 17067801
    [Abstract] [Full Text] [Related]

  • 39. Chemopreventive action of dexamethasone and alpha-tocopherol in oxidative stressed cells.
    Baumeister P, Korn G, Berghaus A, Matthias C, Harréus U.
    Cancer Detect Prev; 2009 Jan 15; 32(5-6):452-7. PubMed ID: 19070971
    [Abstract] [Full Text] [Related]

  • 40. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
    Arunasree KM, Roy KR, Anilkumar K, Aparna A, Reddy GV, Reddanna P.
    Leuk Res; 2008 Jun 15; 32(6):855-64. PubMed ID: 18083230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.